- 询价
- Miltenyi Biotec
- 德国
- 130-127-209
- 2025年12月09日
- Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- human cell line
- human, mouse, non-human primate, other
企业认证
相关产品推荐更多 >
Vimentin Antibody, anti-human, FITC, REAfinity™, 30 tests in 60 µL
询价HLA-DR Antibody, anti-human, VioGreen™, REAfinity™, 100 tests in 200 µL
询价
CD4 (Domain 2) Antibody, anti-rat, APC-Vio® 770, REAfinity™, 9 µg in 300 µL
询价
IL-4 Antibody, anti-mouse, PE, 30 µg in 200 µL
询价AN2 Antibody, anti-human/mouse, PE, 30 tests in 60 µL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
CD49f
- 亚型：
recombinant human IgG1
- 形态：
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件：
避光，4-8℃
- 克隆性：
REA518
- 标记物：
Vio Bright V423
- 适应物种：
human, mouse, non-human primate, other
- 保质期：
24个月
- 供应商：
Miltenyi biotec
- 宿主：
human cell line
- 应用范围：
Flow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 浓度：
1:50
- 抗体英文名：
CD49f Antibody, anti-human/mouse, REAfinity™
- 抗体名：
CD49f Antibody, anti-human/mouse, REAfinity™
- 规格：
100 tests in 200 µL
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验7.5, 150 mM NaCl, and1% (v/v) Triton X-100. 7. Suitable SDS-PAGE and transfer setup as in Section 2.4.1 . 8. Protein Sample Loading Dye (4×) as in Section 2.4.1 . 9. Nitrocellulose or PVDF membrane. 10. Mouse anti-β-catenin antibody (available
for cell lysis: 10 mM Tris-HCl, pH 7.4,50 mM NaCl, 5 mM EDTA, 50 mM NaF, 30 mM Na 4 P 2 O 7 ,and 1% (v/v) Triton-X100. 5. Protease inhibitors and phosphatase inhibitor are added fresheach time with the following final concentrations: 10 μg/mLaprotinin
Clinical Chemistry and Other Laboratory Tests on Mouse Plasma or Serum
. Haller, F., Prehn, C., and Adamski, J. 2010. Quantification of steroids in human and mouse plasma using online solid phase extraction coupled to liquid chromatography tandem mass spectrometry. Nat. Protoc. 10
技术资料暂无技术资料 索取技术资料
